Ann: US FDA Completes Review of IHL-42x IND Application, page-5

Clearly the biggest milestone in the companies history.

!!! IND Application for IHL-42X by US FDA has been completed !!!

This statement will get the attention of the pharmaceutical / medical investment world.
It has been a long journey to this point, many years..... however we are now here at the starting line with powder in the gun. Well done Joel and the entire team.

It is understandable why, big pharmaceutical companies don't look at many start-ups until phase 2/3.... Our clinical programs are clear evidence that if done correctly, they take many years..... and in fact, most don't make it!!!

It is also understandable why pharmaceutical companies pay so much for a drug candidate's in the late stage of development - Phase 2/3.... It usually takes many hundreds of millions to arrive at this point...

Incannex have been very smart & efficient with time and $$ to get a drug candidate to this point....

IHL-42x has ticked off another major risk reduction milestone and with that, has increased it's underlying value.
IHL-42x was valued by Edison around $750M US before the IND opening & when revalued now, will command north of $1 Billion.

It is my opinion, that this drug candidate IHL-42x with an open IND completed is worth at least all time high prices of approx 70c or North of $1B MC.

On top of this, there is plenty of extra value in the additional assets, starting with IHL-675!!!

Good luck friends. Hope to see the investment world wake up to this.